RxDoctor Payments Data

Ambarish Bhat, MD

Vascular & Interventional Radiology · Springfield, MONPI 1316102080

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,413 of the $6,843 with a category attached, or 64.5%. 17 manufacturers reported payments, led by Inari Medical, Inc. at 45.0% of the total. Reporting peaked in 2022 at $3,079 and has fallen 83.7% since, to $502 in 2025.

$6,843in general payments, 2019–2025

Across 90 payments — averaging $76.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$3K
  • Terumo Medical Corporation$852
  • Boston Scientific$534
  • Medtronic$520
  • Johnson & Johnson$456
  • Sirtex Medical Inc$289
  • plus $1K from 11 others
$102,981in research payments, 2019–2025

Across 61 payments — averaging $1688.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Inari Medical, Inc.$90K
  • Stryker$13K

What the payments were for

  • Consulting fees$2,00029%
  • Travel & lodging$3405%
  • Food & beverage$4,41364%
  • Education$901%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,843 in reported general payments places this provider in the 60th percentile of 81 vascular & interventional radiology providers in Missouri.

See all vascular & interventional radiology providers in Missouri

Medicare billing

Part B allowed, 2024
$235,072
Medicare patients
2,240
Services billed
3,890

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →